Edition:
United Kingdom

Perrigo Company PLC (PRGO.N)

PRGO.N on New York Stock Exchange

92.93USD
2:35pm GMT
Change (% chg)

$-0.51 (-0.55%)
Prev Close
$93.44
Open
$92.66
Day's High
$92.96
Day's Low
$92.38
Volume
12,564
Avg. Vol
326,197
52-wk High
$93.46
52-wk Low
$63.69

Select another date:

Mon, Jan 8 2018

BRIEF-Perrigo Says In Connection With Uwe Röhrhoff's Appointment As CEO, Co's Unit Perrigo DAC Entered Into Employment Agreement With Him

* PERRIGO COMPANY - IN CONNECTION WITH UWE RÖHRHOFF'S APPOINTMENT AS CEO, CO'S UNIT PERRIGO DAC ENTERED INTO AN EMPLOYMENT AGREEMENT WITH HIM

Perrigo hires Gerresheimer ex-boss Rohrhoff as new CEO

Generic drugmaker Perrigo Company Plc appointed Uwe Rohrhoff, former CEO of Gerresheimer AG, as its new chief executive, the company said on Monday.

UPDATE 1-Perrigo hires Gerresheimer ex-boss Rohrhoff as new CEO

Jan 8 Generic drugmaker Perrigo Company Plc appointed Uwe Rohrhoff, former CEO of Gerresheimer AG , as its new chief executive, the company said on Monday.

Perrigo hires Gerresheimer ex-boss Rohrhoff as new CEO

Jan 8 Generic drugmaker Perrigo Company Plc appointed former Gerresheimer AG Chief Executive Uwe Rohrhoff as its new president and CEO, the company said on Monday.

BRIEF-Perrigo appoints Uwe Röhrhoff as CEO

* PERRIGO APPOINTS UWE RÖHRHOFF AS PRESIDENT & CHIEF EXECUTIVE OFFICER

BRIEF-Perrigo Announces Tentative FDA Approval For The Generic Version Of Prolensa Ophthalmic Solution 0.07%

* PERRIGO ANNOUNCES TENTATIVE FDA APPROVAL FOR THE GENERIC VERSION OF PROLENSA® OPHTHALMIC SOLUTION 0.07% Source text for Eikon: Further company coverage:

BRIEF-Perrigo Announces The Launch Of An AB Rated Generic Version Of Mycolog II Cream

* PERRIGO ANNOUNCES THE LAUNCH OF AN AB RATED GENERIC VERSION OF MYCOLOG II CREAM Source text for Eikon: Further company coverage:

BRIEF-Perrigo Company ‍Launch AB Rated Generic Version Of Exalgo 32mg

* PERRIGO COMPANY PLC - ‍LAUNCH OF AN AB RATED GENERIC VERSION OF EXALGO 32MG EXTENDED RELEASE TABLETS C-II​ Source text for Eikon: Further company coverage:

BRIEF-Perrigo Company completes divestiture of API business for $110 million

* Perrigo Company completes divestiture of API business for $110 million Source text for Eikon: Further company coverage:

BRIEF-Perrigo Q3 GAAP EPS $0.31

* Perrigo Company PLC reports third quarter 2017 financial results

Select another date: